From Injection to Capsule – How Supraz-40 and Supraz-D Cover All Aspects of Acid Management

Acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia affect millions globally. Managing these conditions effectively requires fast symptom relief, sustained acid suppression, and flexible treatment options based on patient needs. That’s where SUPRAZ-40 and SUPRAZ-D come in — a powerful duo designed to manage acid-related conditions across all stages of care, from hospital emergencies to daily maintenance.

SUPRAZ-40: Fast-Acting IV Solution for Acute Relief
SUPRAZ-40 is an Esomeprazole Sodium injection (40 mg) formulated for intravenous administration. It plays a critical role in hospital and emergency care, of Supraz-40 and Supraz-D especially when oral intake is not feasible.

Key Features:

• Rapid acid suppression in critically ill or post-operative patients
• Fast onset of action via IV route
• Ideal for use in GERD, erosive esophagitis, and Zollinger-Ellison syndrome
• Trusted in ICU and perioperative environments
• Bypasses the gastrointestinal tract for immediate therapeutic effect
• Enables aggressive acid control in acute settings
• Reduces gastric volume before anesthesia in surgical patients

SUPRAZ-40 provides dependable protection when immediate acid suppression is essential — especially in post-surgical care, ICU settings or patients with severe vomiting or swallowing difficulties.

SUPRAZ-D: Capsule with Dual Action
SUPRAZ-D combines Omeprazole (a Proton Pump Inhibitor) with Domperidone (a prokinetic), delivering dual-action therapy to manage acid production and enhance gastric motility.

Benefits:

• Suppresses acid secretion at the source (Omeprazole)
• Improves gastric emptying and reduces bloating (Domperidone)
• Provides relief from symptoms like nausea, bloating, and heartburn
• Convenient once-daily capsule
• Suitable for long-term GERD, functional dyspepsia, and chronic indigestion
• Enhances treatment adherence due to ease of use
• Helps in preventing disease recurrence by improving gut motility

SUPRAZ-D is especially beneficial for outpatient care, offering sustained symptom control and supporting improved patient quality of life.

Patient-Centered Outcomes
Today’s patients expect more than temporary relief — they demand solutions that are comfortable, comprehensive, and clinically effective.

SUPRAZ Range Supports:

• Rapid symptom control in emergency situations
• Seamless transition from IV to oral therapy
• Prevention of acid-related complications
• Dual-pathway protection (acid suppression + motility regulation)
• Long-term digestive comfort and well-being

Conclusion: Total Acid Management Made Simple
Managing acid-related disorders requires more than just symptom relief — it demands a treatment approach that adapts to the patient’s condition, severity, and lifestyle. Whether it’s rapid control in emergencies with SUPRAZ-40 or sustained, daily relief with SUPRAZ-D, the SUPRAZ range is built to deliver end-to-end acid suppression.

By offering both options of Supraz-40 and Supraz-D, SUPRAZ ensures patients receive the right care at the right time — from hospital to home, from acute rescue to long-term maintenance.

SUPRAZ isn’t just treatment — it’s a complete acid management solution.

Important Reminder:
Always consult your doctor before starting or changing any acid-suppressing therapy. Your treatment should be tailored to your unique clinical needs.